▶ 調査レポート

抗糖尿病薬チアゾリジンジオン市場:世界及び中国市場分析・予測(~2024年)

• 英文タイトル:Antidiabetic Thiazolidinediones Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Prof Researchが調査・発行した産業分析レポートです。抗糖尿病薬チアゾリジンジオン市場:世界及び中国市場分析・予測(~2024年) / Antidiabetic Thiazolidinediones Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 / C9J04271資料のイメージです。• レポートコード:C9J04271
• 出版社/出版日:Prof Research / 2019年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、150ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥444,000 (USD3,000)▷ お問い合わせ
  Site License¥562,400 (USD3,800)▷ お問い合わせ
  Global Site License¥740,000 (USD5,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
世界及び中国における抗糖尿病薬チアゾリジンジオン市場について調査・分析したレポートで、抗糖尿病薬チアゾリジンジオンの世界市場動向、市場規模、主要企業情報などが含まれています。抗糖尿病薬チアゾリジンジオンの種類別には、ロシグリタゾン、ピオグリタゾンに分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・抗糖尿病薬チアゾリジンジオン産業の概要
・抗糖尿病薬チアゾリジンジオンの製造技術分析
・主要企業分析:企業概要、製品情報、連絡先など
・世界及び中国の抗糖尿病薬チアゾリジンジオン市場 2014年-2019年
・世界及び中国の抗糖尿病薬チアゾリジンジオン市場現状
・企業別分析:Sanofi, Takeda Pharmaceuticals, Eli Lilly, Merck and Co., Novo Nordisk, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Boehringer Ingelheimなど
・地域別分析:アメリカ、ヨーロッパ、日本、中国など
・種類別分析:ロシグリタゾン、ピオグリタゾン
・世界及び中国の抗糖尿病薬チアゾリジンジオン市場予測 2019年-2024年
・抗糖尿病薬チアゾリジンジオンの産業チェーン分析
・世界及び中国のマクロ経済動向と影響
・世界及び中国の抗糖尿病薬チアゾリジンジオン市場動向・課題・機会
・新規プロジェクトへの提言・結論

Antidiabetic Thiazolidinediones Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antidiabetic Thiazolidinediones industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antidiabetic Thiazolidinediones manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Antidiabetic Thiazolidinediones market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Antidiabetic Thiazolidinediones industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Antidiabetic Thiazolidinediones industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Antidiabetic Thiazolidinediones Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Antidiabetic Thiazolidinediones as well as some small players. At least 10 companies are included:
* Sanofi
* Takeda Pharmaceuticals
* Eli Lilly
* Merck and Co.
* Novo Nordisk
* Bristol-Myers Squibb
For complete companies list, please ask for sample pages.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Antidiabetic Thiazolidinediones market in gloabal and china.
* Rosiglitazone
* Pioglitazone

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospitals
* Clinics
* Other

Reasons to Purchase this Report:

* Estimates 2019-2024 Antidiabetic Thiazolidinediones market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Chapter One Introduction of Antidiabetic Thiazolidinediones Industry
1.1 Brief Introduction of Antidiabetic Thiazolidinediones
1.2 Development of Antidiabetic Thiazolidinediones Industry
1.3 Status of Antidiabetic Thiazolidinediones Industry

Chapter Two Manufacturing Technology of Antidiabetic Thiazolidinediones
2.1 Development of Antidiabetic Thiazolidinediones Manufacturing Technology
2.2 Analysis of Antidiabetic Thiazolidinediones Manufacturing Technology
2.3 Trends of Antidiabetic Thiazolidinediones Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Sanofi
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Takeda Pharmaceuticals
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Eli Lilly
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Merck and Co.
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Novo Nordisk
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of Antidiabetic Thiazolidinediones
4.1 2014-2019 Global Capacity, Production and Production Value of Antidiabetic Thiazolidinediones Industry
4.2 2014-2019 Global Cost and Profit of Antidiabetic Thiazolidinediones Industry
4.3 Market Comparison of Global and Chinese Antidiabetic Thiazolidinediones Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Antidiabetic Thiazolidinediones
4.5 2014-2019 Chinese Import and Export of Antidiabetic Thiazolidinediones

Chapter Five Market Status of Antidiabetic Thiazolidinediones Industry
5.1 Market Competition of Antidiabetic Thiazolidinediones Industry by Company
5.2 Market Competition of Antidiabetic Thiazolidinediones Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Antidiabetic Thiazolidinediones Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese Antidiabetic Thiazolidinediones Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Antidiabetic Thiazolidinediones
6.2 2019-2024 Antidiabetic Thiazolidinediones Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Antidiabetic Thiazolidinediones
6.4 2019-2024 Global and Chinese Supply and Consumption of Antidiabetic Thiazolidinediones
6.5 2019-2024 Chinese Import and Export of Antidiabetic Thiazolidinediones

Chapter Seven Analysis of Antidiabetic Thiazolidinediones Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Antidiabetic Thiazolidinediones Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Antidiabetic Thiazolidinediones Industry

Chapter Nine Market Dynamics of Antidiabetic Thiazolidinediones Industry
9.1 Antidiabetic Thiazolidinediones Industry News
9.2 Antidiabetic Thiazolidinediones Industry Development Challenges
9.3 Antidiabetic Thiazolidinediones Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Antidiabetic Thiazolidinediones Industry

Tables and Figures
Figure Antidiabetic Thiazolidinediones Product Picture
Table Development of Antidiabetic Thiazolidinediones Manufacturing Technology
Figure Manufacturing Process of Antidiabetic Thiazolidinediones
Table Trends of Antidiabetic Thiazolidinediones Manufacturing Technology
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
Figure Antidiabetic Thiazolidinediones Product and Specifications
Table 2014-2019 Antidiabetic Thiazolidinediones Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2014-2019 Antidiabetic Thiazolidinediones Production Global Market Share
……
……
Table 2014-2019 Global Antidiabetic Thiazolidinediones Capacity List
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Manufacturers Capacity Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Manufacturers Capacity Share
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Manufacturers Production List
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Manufacturers Production Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Manufacturers Production Share
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Manufacturers Production Value List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Production Value and Growth Rate
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Manufacturers Production Value Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Manufacturers Production Value Share
Table 2014-2019 Global Antidiabetic Thiazolidinediones Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Antidiabetic Thiazolidinediones Production
Table 2014-2019 Global Supply and Consumption of Antidiabetic Thiazolidinediones
Table 2014-2019 Import and Export of Antidiabetic Thiazolidinediones
Figure 2018 Global Antidiabetic Thiazolidinediones Key Manufacturers Capacity Market Share
Figure 2018 Global Antidiabetic Thiazolidinediones Key Manufacturers Production Market Share
Figure 2018 Global Antidiabetic Thiazolidinediones Key Manufacturers Production Value Market Share
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Capacity List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Capacity
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Capacity Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Capacity Share
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Production List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Production
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Production Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Production Share
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Consumption Volume List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Consumption Volume
Table 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Consumption Volume Share List
Figure 2014-2019 Global Antidiabetic Thiazolidinediones Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Antidiabetic Thiazolidinediones Consumption Volume Market by Application
Table 89 2014-2019 Global Antidiabetic Thiazolidinediones Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Antidiabetic Thiazolidinediones Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Antidiabetic Thiazolidinediones Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Antidiabetic Thiazolidinediones Consumption Volume Market by Application
Figure 2019-2024 Global Antidiabetic Thiazolidinediones Capacity Production and Growth Rate
Figure 2019-2024 Global Antidiabetic Thiazolidinediones Production Value and Growth Rate
Table 2019-2024 Global Antidiabetic Thiazolidinediones Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Antidiabetic Thiazolidinediones Production
Table 2019-2024 Global Supply and Consumption of Antidiabetic Thiazolidinediones
Table 2019-2024 Import and Export of Antidiabetic Thiazolidinediones
Figure Industry Chain Structure of Antidiabetic Thiazolidinediones Industry
Figure Production Cost Analysis of Antidiabetic Thiazolidinediones
Figure Downstream Analysis of Antidiabetic Thiazolidinediones
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Antidiabetic Thiazolidinediones Industry
Table Antidiabetic Thiazolidinediones Industry Development Challenges
Table Antidiabetic Thiazolidinediones Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Antidiabetic Thiazolidinedioness Project Feasibility Study